ClearPoint Neuro, Inc. (CLPT) has seen some recent action in the marketplace and its shares finished trading at $3.1700 yesterday. People are starting to take interest of CLPT as the shares traded as high as $3.4000 and as low as $2.8973 in the prior market session.
ClearPoint Neuro, Inc. (CLPT) average trading volume is 44.19K. However, in the prior market session ClearPoint Neuro, Inc. (CLPT) exchanged 231,896 shares. The 1st downside support level on CLPT is $3.08 and the 1st resistance level on CLPT is $6.10. CLPT 50-day moving average is $3.5863 and CLPT two hundred day moving average is $4.0889.
ClearPoint Neuro, Inc. (CLPT) recent performance has been indicated by the recent movement in CLPT shares. CLPT has performed -17.45% over the past month, CLPT has performed -43.49% over the past 3 months and CLPT has shown -5.37% over the past 1 year. ClearPoint Neuro, Inc. (CLPT) has a 12 month range of $2.8600 to $6.3300. ClearPoint Neuro, Inc. (CLPT) is trading 10.84% from its 12 month low and -49.92% from its 12 month high. ClearPoint Neuro, Inc. (CLPT) is indicating a 0.12% short float indicating the amount short in the float.
CLPT has 15.76M shares outstanding and 8.46M shares in the float. ClearPoint Neuro, Inc. (CLPT) presently has a market cap of $49.96M and income of $-5.50M. The EPS next quarter for CLPT is -0.18 and anticipated EPS net year is 40.70%. The market cap of ClearPoint Neuro, Inc. (CLPT) at $49.96M signifies how many People own shares of CLPT and is calculated off the last price ($3.1700) of CLPT and the amount of shares outstanding (15.76M) with ClearPoint Neuro, Inc. (CLPT).
ClearPoint Neuro, Inc. (CLPT) has total cash (mrq) of 5.7M, total cash per share (mrq) of 0.37, total debt of CLPT is at 2.46M and total debt/equity (mrq) is 53.69. ClearPoint Neuro, Inc. (CLPT) operating cash flow (ttm) is -2.85M and CLPT leveraged free cash flow (ttm) is -1.13M.
CLPT is trading -12.61% below (bearish) its SMA20, -15.72% below (bearish) its SMA50 and -26.43% below (bearish) its SMA200.
Recent News:
In recent news, on May 12, 2020, it is stated, Company Provides Update on Effects of COVID-19 Pandemic ClearPoint Neuro, Inc. (CLPT) announced financial results for its first fiscal quarter ended March 31, 2020.
About ClearPoint Neuro, Inc. (CLPT):
ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc.
